Newsfeeds - Spark Newswire

7 minute read

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO

Today, 4:18 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4)

ABSI

7 minute read

88 Biggest Movers From Yesterday

By Lisa Levin

Today, 4:18 AM

Gainers

ABSI

34 minute read

Earnings Scheduled For August 5, 2021

By Benzinga Insights

Today, 4:18 AM

Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.

AAOI

1 minute read

WHO Asks To Hold Off COVID-19 Vaccine Booster Shots Citing Inequality: Report

By Vandana Singh

Today, 4:18 AM

The World Health Organization (WHO) has called on wealthy nations to stop the distribution of COVID-19 booster shots, citing vaccine inequity worldwide. The World Health Organization called for a moratorium on booster shots until at least the end of September because of a shortfall in vaccine supplies to developing countries.

AZN

2 minute read

Why Novavax Looks Like It Could Be Breaking Out

By Tyler Bundy

Today, 4:18 AM

Novavax, Inc. (NASDAQ: NVAX) shares rallied higher Wednesday after the company announced it finalized an advanced purchase agreement with the European Commission for the purchase of up to 200 million doses of its COVID-19 vaccine. Novavax was up 20.50% at $227.73 at last check Wednesday.

NVAX

5 minute read

58 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

Today, 4:18 AM

Gainers

ACY

1 minute read

Why Novavax’s Stock Is Trading Higher Today

By Adam Eckert

Today, 4:18 AM

Novavax Inc (NASDAQ: NVAX) is trading higher Wednesday morning after the company announced it finalized an advanced purchase agreement with the European Commission for the purchase of up to 200 million doses of its COVID-19 vaccine.

NVAX

2 minute read

Novavax, European Commission Finalize Advance Purchase Deal For Up To 200M Doses Of COVID-19 Vaccine, No Terms Disclosed

By Benzinga Newsdesk

Today, 4:18 AM

-- Agreement for 100 million doses with option for additional 100 million doses through 2023 -- Expected to be the first protein subunit COVID-19 vaccine available in the European Union GAITHERSBURG, Md., Aug. 4, 2021

NVAX

6 minute read

The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs

By Shanthi Rexaline

Today, 4:18 AM

Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies.

ABUS

2 minute read

Understanding Novavax’s Unusual Options Activity

By Benzinga Insights

Today, 4:18 AM

Shares of Novavax (NASDAQ:NVAX) saw some unusual options activity on Monday. Following the unusual option alert, the stock price moved down to $194.79.

NVAX